All Stories

  1. The Efficacy, Feasibility And Acceptability Of A Remotely Accessible Use Of CIRCuiTS, A Computerized Cognitive Remediation Therapy Program For Schizophrenia: A Pilot Study
  2. Impact of Reward and Loss Anticipation on Cognitive Control: An Event-Related Potential Study in Subjects With Schizophrenia and Healthy Controls
  3. Electrophysiological and Neuroimaging Research on Negative Symptoms: Future Challenges
  4. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives
  5. SoCIAL – training cognition in schizophrenia: a pilot study
  6. The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia
  7. Is avolition in schizophrenia associated with a deficit of dorsal caudate activity? A functional magnetic resonance imaging study during reward anticipation and feedback
  8. The Specific Level of Functioning Scale: Construct validity, internal consistency and factor structure in a large Italian sample of people with schizophrenia living in the community
  9. Negative Symptoms in Schizophrenia
  10. Electrophysiological Aberrations Associated with Negative Symptoms in Schizophrenia
  11. Physiological Correlates of Positive Symptoms in Schizophrenia
  12. Neurocognitive individualized training versus social skills individualized training: A randomized trial in patients with schizophrenia
  13. Categorical and dimensional approaches to negative symptoms of schizophrenia: Focus on long-term stability and functional outcome
  14. Persistent negative symptoms in first episode patients with schizophrenia: Results from the European First Episode Schizophrenia Trial
  15. Impulsiveness in Patients with Bulimia Nervosa: Electrophysiological Evidence of Reduced Inhibitory Control
  16. Dorsolateral prefrontal cortex volume in patients with deficit or nondeficit schizophrenia
  17. Survival from coma induced by an intentional 36-g overdose of extended-release quetiapine
  18. Normal EEG Patterns and Waveforms
  19. Effects of Psychotropic Drugs on EEG
  20. NRG1 and BDNF genes in schizophrenia: An association study in an Italian case-control sample
  21. Correlates of cognitive impairment in first episode schizophrenia: The EUFEST study
  22. Oxytocin receptor polymorphisms and adult attachment style in patients with depression
  23. Social skills and neurocognitive individualized training in schizophrenia: comparison with structured leisure activities
  24. Mutation analysis of oxytocin gene in individuals with adult separation anxiety
  25. Ala147Thr substitution in translocator protein is associated with adult separation anxiety in patients with depression
  26. Cerebral connectivity and psychotic personality traits
  27. Alexithymia and Cognitive Dysfunctions in Patients with Panic Disorder
  28. Cognitive-enhancing effects of aripiprazole: a case report
  29. Double dissociation of N1 and P3 abnormalities in deficit and nondeficit schizophrenia
  30. Sources of cortical rhythms in adults during physiological aging: A multicentric EEG study
  31. Selected E-ISNR 2004 Conference Presentation Abstracts
  32. Hemispheric lateralization patterns and psychotic experiences in healthy subjects
  33. Modified nutritional counselling to increase motivation to treatment in anorexia nervosa
  34. EEG microstate duration and syntax in acute, medication-naïve, first-episode schizophrenia: a multi-center study
  35. COMT Val158Met and BDNF C270T polymorphisms in schizophrenia: a case-control study
  36. Catechol-O-Methyltransferase Val158Met Polymorphism in Schizophrenia: Associations with Cognitive and Motor Impairment
  37. The contribution of brain imaging to the study of panic disorder
  38. Executive hypercontrol in obsessive–compulsive disorder: electrophysiological and neuropsychological indices
  39. Inhibition of auditory cortical responses to ipsilateral stimuli during dichotic listening: evidence from magnetoencephalography
  40. Neurocognitive functioning in subjects with eating disorders: the influence of neuroactive steroids
  41. Historical, Psychopathological, Neurological, and Neuropsychological Aspects of Deficit Schizophrenia: A Multicenter Study
  42. Hemispheric asymmetry and psychopathological dimensions in drug-free patients with schizophrenia
  43. ‘Simple schizophrenia’: a controlled MRI and clinical/neuropsychological study
  44. Multilead quantitative EEG profile of clozapine in resting and vigilance-controlled conditions
  45. Influence of Moclobemide on Cognitive Functions of Nine Depressed Patients: Pilot Trial with Neurophysiological and Neuropsychological Indices
  46. QEEG alpha1 changes after a single dose of high-potency neuroleptics as a predictor of short-term response to treatment in schizophrenic patients
  47. Computerized EEG topography findings in schizophrenic patients before and after haloperidol treatment
  48. CEEG mapping in drug-free schizophrenics
  49. Dynamic brain mapping methodology and application
  50. C-EEG brain mapping in DSM-III schizophrenics after acute and chronic haloperidol treatment
  51. Conditional Associative Learning in Drug-Free Schizophrenic Patients